Alberto Toso
Company: Alentis Therapeutics
Job title: Chief Scientific Officer
Seminars:
Claudin 1: in Cancer & Organ Fibrosis 2:15 pm
Examining the role of Claudin 1 in cancer and organ fibrosis Discussing the pre-clinical development and the therapeutic potential of monoclonal antibodies and ADCs targeting Claudin 1 Addressing the phase I development for Claudin 1-targeted therapiesRead more
day: Conference Day 1